ACXP

ACURX PHARMACEUTICALS INC

ACXP·00510M203·US·Common Stock·Healthcare - Biotechnology-13D/G

ACXP (ACURX PHARMACEUTICALS INC) is held by 13 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($48,203), GEODE CAPITAL MANAGEMENT, LLC ($40,938), VANGUARD FIDUCIARY TRUST CO ($25,118). Net institutional sentiment: Mixed.

13
Holders
$161,992
Total Value
44% (9)
Consensus
4 buying - 5 selling
13F: Insider & Congress: Updated regularly
ACXP

Smart Money Verdict

View all
Loading verdict
Held by 13 funds

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders none · Activists Aug 14, 2025 · Congress none

ActivistARArmistice Capital, LLC10.0%Aug 14, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
31,099$48,2030.0%-2.70%
0
Increased
26,411(+6.4%)$40,9380.0%-28.72%
15
Unchanged
16,205$25,1180.0%-2.70%
0
Decreased
15,727(-71.2%)$24,3770.0%-15.50%
0
Increased
7,500(+15.4%)$11,6250.0%-93.24%
14
New
4,729$7,3300.0%-7.10%
25
Unchanged
2,300$3,5650.0%-45.04%
0
Decreased
281(-26.1%)$4360.0%-2.70%
0
Unchanged
100$1550.0%-97.76%
0
Decreased
95(-61.2%)$1470.0%-85.20%
0
Unchanged
60$930.0%-90.33%
0
Decreased
3(-100.0%)$50.0%-4.67%
0
Exited
0(-100.0%)$40.0%-63.79%
0
New
0$00.0%-7.10%
17
ACXPACXPACURX PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used